Intravitreal bevacizumab monotherapy for type-1 prethreshold, threshold, and aggressive posterior retinopathy of prematurity-27 month follow-up results from Turkey

Date
2015
Author
günay, Murat
Salihoglu, Ziya
Sirop, Sarkis
Yetik, Huseyin
Metadata
Show full item record
Abstract
To study the efficacy of intravitreal bevacizumab (IVB) injection as a single treatment for retinopathy of prematurity (ROP).
URI
http://hdl.handle.net/20.500.12627/13839
https://doi.org/10.1007/s00417-014-2867-0
Collections